Literature DB >> 4040355

Intolerance to cisplatin--a case report.

G E Umbach, H von Matthiessen, G Wirth, G Goerz.   

Abstract

A patient who had a systemic reaction to cisplatin chemotherapy had a reaction to subsequent i.c. and i.v. test doses. Notwithstanding she had a more severe systemic reaction during a further course of cisplatin chemotherapy.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4040355     DOI： 10.1007/bf02133962

Source DB:  PubMed          Journal:  Arch Gynecol        ISSN： 0170-9925


  11 in total

1.  Phase II study of cis-dichlorodiammineplatinum(II) in childhood osteosarcoma: Children's Cancer Study Group Report.

Authors:  E S Baum; P Gaynon; L Greenberg; W Krivit; D Hammond
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct

Review 2.  Toxic effects of cis-dichlorodiammineplatinum(II) in man.

Authors:  D D Von Hoff; R Schilsky; C M Reichert; R L Reddick; M Rozencweig; R C Young; F M Muggia
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct

3.  Treatment of genitourinary tumours with cis-dichlorodiammineplatinum(II): experience in 250 patients.

Authors:  C E Merrin
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct

4.  Chemotherapy for testicular cancer: current status of the National Cancer Institute Combined Modality Trial.

Authors:  T Anderson; N Javadpour; R Schilsky; A Barlock; R C Young
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct

5.  Platinum and platinosis. Allergy and histamine release due to some platinum salts.

Authors:  J L Parrot; R Hébert; A Saindelle; F Ruff
Journal:  Arch Environ Health       Date:  1969-11

6.  Atopic hypersensitivity to cis-dichlorodiammineplatinum(II) and other platinum complexes.

Authors:  A Khan; J M Hill; W Grater; E Loeb; A MacLellan; N Hill
Journal:  Cancer Res       Date:  1975-10       Impact factor: 12.701

Review 7.  Hypersensitivity reactions to cancer chemotherapeutic agents.

Authors:  R B Weiss; S Bruno
Journal:  Ann Intern Med       Date:  1981-01       Impact factor: 25.391

8.  Successful re-treatment with cis-dichlorodiammineplatinum(II) after apparent allergic reactions.

Authors:  M Wiesenfeld; E Reinders; M Corder; T J Yoo; B Dietz; J Lovett
Journal:  Cancer Treat Rep       Date:  1979-02

9.  Toxicity of cis-diamminedichloroplatinum II given in a two-hour outpatient regimen of diuresis and hydration.

Authors:  S E Vogl; T Zaravinos; B H Kaplan
Journal:  Cancer       Date:  1980-01-01       Impact factor: 6.860

10.  High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis.

Authors:  D M Hayes; E Cvitkovic; R B Golbey; E Scheiner; L Helson; I H Krakoff
Journal:  Cancer       Date:  1977-04       Impact factor: 6.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.